Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis
1 other identifier
observational
37
1 country
1
Brief Summary
The objective of this study is to evaluate the accuracy of trapeziometacarpal injections using palpation alone. The importance of this study is one of education, cost containment, and decreased risk to the patient. If it can be shown that the accuracy of trapeziometacarpal injections using palpation alone is similar to the reported accuracy of ultrasound and fluoroscopy, then these guided techniques may not be needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 8, 2017
CompletedFirst Posted
Study publicly available on registry
May 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2017
CompletedSeptember 24, 2024
September 1, 2024
5 months
May 8, 2017
September 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of injection
Accuracy judged in a blinded fashion, rated injection in joint or out of joint
radiograph immediately after injection (<5 mins)
Interventions
Contrast dye will be included in the standard injection of lidocaine and corticosteroid. After injection, the participant will have 2 radiograph views of the thumb.
Eligibility Criteria
All patients diagnosed with trapeziometacarpal arthritis and a treatment plan including intra-articular steroid injections
You may qualify if:
- The patient has clinical signs of trapeziometacarpal arthritis and are willing to obtain a post injection x-ray
- The patient is over the age of 18 years of age.
You may not qualify if:
- The patient has a known allergy to contrast dye
- The patient has a planned surgery on the trapeziometacarpal joint within 6 weeks following injection
- Patients who are pregnant or believe they may be pregnant
- Prisoners
- Patients who are unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hand Center
Greenville, South Carolina, 29615, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Sanders, MD
Prisma Health-Upstate
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2017
First Posted
May 10, 2017
Study Start
May 1, 2017
Primary Completion
September 15, 2017
Study Completion
September 15, 2017
Last Updated
September 24, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share